A citation-based method for searching scientific literature

Volker M Lauschke, Lili Milani, Magnus Ingelman-Sundberg. AAPS J 2017
Times Cited: 74







List of shared articles



Times cited

Technologies for Pharmacogenomics: A Review.
Maaike van der Lee, Marjolein Kriek, Henk-Jan Guchelaar, Jesse J Swen. Genes (Basel) 2020
11

Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics.
Maria-Theodora Pandi, Marc S Williams, Peter van der Spek, Maria Koromina, George P Patrinos. Genes (Basel) 2020
3



Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
Sulev Reisberg, Kristi Krebs, Maarja Lepamets, Mart Kals, Reedik Mägi, Kristjan Metsalu, Volker M Lauschke, Jaak Vilo, Lili Milani. Genet Med 2019
46



Pharmacogenetics of HIV therapy: challenges for tailoring treatment in genetically complex populations.
Camila de Almeida Velozo, Cynthia Chester Cardoso. Pharmacogenomics 2022
0

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data.
Yitian Zhou, Kohei Fujikura, Souren Mkrtchian, Volker M Lauschke. Front Pharmacol 2018
42


Integrating rare genetic variants into pharmacogenetic drug response predictions.
Magnus Ingelman-Sundberg, Souren Mkrtchian, Yitian Zhou, Volker M Lauschke. Hum Genomics 2018
103

Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Laura E Russell, Yitian Zhou, Ahmed A Almousa, Jasleen K Sodhi, Chukwunonso K Nwabufo, Volker M Lauschke. Drug Metab Rev 2021
11

A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants.
Maria-Theodora Pandi, Maria Koromina, Iordanis Tsafaridis, Sotirios Patsilinakos, Evangelos Christoforou, Peter J van der Spek, George P Patrinos. Hum Genomics 2021
5


Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response.
Janet Piñero, Abel Gonzalez-Perez, Emre Guney, Joaquim Aguirre-Plans, Ferran Sanz, Baldo Oliva, Laura I Furlong. Front Genet 2018
6


An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Yitian Zhou, Souren Mkrtchian, Masaki Kumondai, Masahiro Hiratsuka, Volker M Lauschke. Pharmacogenomics J 2019
65

Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals.
Camila de Almeida Velozo, Tailah Bernardo de Almeida, Marcelo Costa Velho Mendes de Azevedo, Isabela Espasandin, Jorge Francisco da Cunha Pinto, Sheila López, Luciana Pizzatti, Amilcar Tanuri, Sabrina da Silva Santos, Marcelo Ribeiro-Alves,[...]. Pharmacogenomics J 2022
1

Challenges and opportunities associated with rare-variant pharmacogenomics.
Yitian Zhou, Roman Tremmel, Elke Schaeffeler, Matthias Schwab, Volker M Lauschke. Trends Pharmacol Sci 2022
1


Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment.
Leyre Pernaute-Lau, Ayola Akim Adegnika, Yitian Zhou, Jeannot F Zinsou, Jose Pedro Gil, Sanjeev Krishna, Peter G Kremsner, Volker M Lauschke, Thirumalaisamy P Velavan. Antimicrob Agents Chemother 2021
6



Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
Tõnis Tasa, Kristi Krebs, Mart Kals, Reedik Mägi, Volker M Lauschke, Toomas Haller, Tarmo Puurand, Maido Remm, Tõnu Esko, Andres Metspalu,[...]. Eur J Hum Genet 2019
19